Skip to Main Content

Paper Details

Evolution of delayed resistance to immunotherapy in a melanoma responder.
Nat Med
57
2021
ICB, NGFR, NGFRhi, NGFRhi tumor cells, PD-L1, RNA, chromosome 15q, de-differentiated neural-crest tumor, de-differentiated neural-crest tumor population, immune cells, lung tumors, melanoma, metastatic melanoma, patient, patients, post-treatment clones, recurrent, subcutaneous tumors, tumor, tumor cells, tumors
Author NameAffiliation
Jia-Ren LinHarvard Medical School
Adam A KrayaPerelman School of Medicine at the University of Pennsylvania
Adam A KrayaPerelman School of Medicine at the University of Pennsylvania
Gao ZhangThe Wistar Institute
Gao ZhangDuke University School of Medicine
Mai P HoangHarvard Medical School, Massachusetts General Hospital
Priscilla K BrastianosMassachusetts General Hospital Cancer Center, Harvard Medical School
Eytan RuppinNational Cancer Institute, National Institutes of Health
Meenhard HerlynThe Wistar Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenBroad Institute of Harvard and MIT
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenBroad Institute of Harvard and MIT
Katherine L NathansonPerelman School of Medicine at the University of Pennsylvania
Katherine L NathansonBasser Center for BRCA, Perelman School of Medicine at the University of Pennsylvania
Katherine L NathansonAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Manolis KellisBroad Institute of Harvard and MIT
Manolis KellisMassachusetts Institute of Technology
Manolis KellisBroad Institute of Harvard and MIT
Manolis KellisMassachusetts Institute of Technology
Peter K SorgerHarvard Medical School
Peter K SorgerHarvard Medical School
  • 1 - 22

Datasets

Release 1.2